Category

Clinical Trials

Per Norlen Photo Jenny Leyman

Evaxion announces Phase 1/2a results

November 18, 2022

Evaxion Biotech has announced clinical …

EpiEndo initiates Phase 2a trial

November 15, 2022

EpiEndo Pharmaceuticals has received regulatory …

Affibody’s partner announces positive Phase I results

November 9, 2022

Affibody’s licensee Rallybio Corporation has …

Göran Forsberg Photo Håkan Sandbring

Cantargia reports new promising data

November 8, 2022

Cantargia has reported new data …

Patric Stenberg

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis

November 1, 2022

Gesynta Pharma has announced the …

Ultimovacs lab

First patient randomized in Ultimovacs’ LUNGVAC trial

October 26, 2022

Ultimovacs has announced that the …

Martin Olin

BerGenBio initiates Phase 1b/2a trial

October 14, 2022

BerGenBio has announced the initiation …

Nykode announces positive Phase 1/2 results

October 14, 2022

Nykode Therapeutics has announced clinical …

First US patient dosed in TILT’s Phase I study

October 11, 2022

TILT Biotherapeutics has announced that …

Orexo announces positive Phase I data

October 11, 2022

Orexo has announced positive results …

Ultimovacs announces positive three-year results

October 10, 2022

Ultimovacs has announced continuing positive …

Søren Bregenholt

Alligator announces positive safety data

October 5, 2022

Alligator Bioscience has reported positive …

Positive results from BioArctic’s Alzheimer’s study

September 29, 2022

BioArctic’s partner Eisai has announced …

Empros Pharma results published in scientific journal

September 27, 2022

The company’s study is published …

Carl-Magnus Högerkorp

Cyxone receives green light to start Phase 2b study

September 20, 2022

Cyxone has received approvals from …

AlzeCure reports new data from Phase I study

September 16, 2022

AlzeCure Pharma has received new …

1
2
3
···
44